10th Indian Delegation to Dubai, Gitex & Expand North Star – World’s Largest Startup Investor Connect
Wellness

Lehar Footwears announced H1FY26 and Q2FY26 results, Reports Strong Revenue and PAT Growth


Jaipur (Rajasthan) [India], November 10: Lehar Footwears Limited (‘Lehar’) announced its results for the quarter ended 30th September, 2025.

Financial Highlights: H1FY26 vs H1FY25 Comparison

  • Delivered a strong performance in H1FY26, with sales rising to ₹282.7 crore from ₹100.8 crore in H1FY25 and ₹277.2 crore in FY25.
  • PAT surged to ₹14.6 crore against ₹3.6 crore in H1FY25 and Rs 10.9 crore in FY25. PAT margin improved to 5.2% from 3.6%, driven by higher operating…



Source link

by Team SNFYI

WiseLife, one-stop-solution for all yoga & home fitness essentials, previously featured in Shark Tank India Season 3, has raised ₹8 crore in a Seed/Pre-Series A round from Rukam Capital. The strategic investment marks a pivotal step in WiseLife’s mission to become India’s go-to brand for premium, eco-friendly yoga mats and other wellness products that blend unique design with affordability. Founded with the vision to elevate everyday wellness through thoughtfully designed yoga gear, WiseLife has struck a chord with India’s growing base of health-conscious consumers. The brand offers a curated range of biodegradable yoga mats, fitness gear, and lifestyle accessories, combining durability, design, and sustainability at accessible price points. “The current funding round will help us scale WiseLife from a boutique brand to India’s No. 1 yoga brand. We will be able to do a lot more experimenting and develop even better products and content for the yoga and fitness enthusiasts,” said Prateek Kedia, Founder of WiseLife. Speaking on the investment, Archana Jahagirdar, Founder & Managing Partner at Rukam Capital, said  “India is at the cusp of a wellness revolution. WiseLife stands out by creating a brand that is not only functionally superior but also emotionally resonant with today’s health-conscious consumer. We see tremendous potential in the brand’s vision and are excited to back their journey of making yoga more inclusive, aspirational, and accessible.” The new funding from Rukam Capital comes at a time when the yoga and wellness space is witnessing exponential growth. According to IMARC Group, India’s yoga mat market is projected to grow from USD 1.4 billion in 2024 to USD 2.2 billion by 2033, while the global market is expected to reach USD 26.5 billion by 2030. Rising health consciousness, corporate wellness programs, increased adoption of yoga, and a shift toward eco-friendly products are driving this momentum. WiseLife first gained national visibility after its successful appearance on Shark Tank India Season 3, where it bagged funding from all four sharks: Aman Gupta, co-founder of boAt; Anupam Mittal, founder and CEO of Shaadi.com; Ritesh Aggarwal, founder and CEO of OYO Rooms; and Namita Thapar, Executive Director of Emcure Pharmaceuticals. The founders’ vision and product strategy resonated with the investors and consumers, setting the stage for further institutional backing. With its strong customer base and growing brand resonance, WiseLife is well-positioned to lead this transformation. The company plans to launch new product lines, enhance content and community engagement, and expand distribution in the coming year. About Rukam CapitalRukam Capital is a leading Indian early-stage venture capital firm specializing in investing in consumer products and services companies. We invest in purpose-led founders who are solving hard problems at scale by creating products and companies that people love. As entrepreneurs ourselves, we understand the challenges of building a successful business and actively partner with our portfolio companies to drive innovation and growth. For more information, visit: www.rukamcapital.com

by Team SNFYI

When it comes to starting any hair fall treatment, one of the biggest concerns people have is about side effects. Understandably so, nobody wants to risk their health or scalp just to stop hair fall. With multi-science solutions like Traya, which combine dermatology, Ayurveda, and nutrition, the question becomes even more relevant. People often search for “side effects of Traya hair treatment reviews” to understand if the treatment is safe. Instead of relying only on scattered opinions, let’s break down the science behind Traya’s approach and what experts say about its safety profile. Why Safety Matters in Hair Fall Treatments Hair fall solutions are not just cosmetic products. They interact with your body — topically, internally, or both. Some of the common concerns include: A multi-science approach like Traya’s involves more than one type of treatment, so understanding each layer is important for safety evaluation. Traya’s Three-Pronged Approach to Safety Traya follows a personalised, doctor-monitored method. Let’s look at each component and its safety considerations. 1. Dermatology: External Treatments and Scalp Health Dermatology in Traya’s plan focuses on topical applications to the scalp. The dermatological aspect of Traya is carefully monitored, reducing the risk of adverse reactions. 2. Ayurveda: Natural, But Still Requires Care Ayurvedic formulations in Traya use herbs like Ashwagandha, Bhringraj, and Brahmi. It’s worth noting that natural does not always mean risk-free, but Traya’s personalised approach helps minimise such concerns. 3. Nutrition: Filling Gaps Safely Traya includes nutritional supplements as part of its treatment plans. By tailoring supplementation, Traya ensures the nutritional aspect remains safe and beneficial. Personalisation: A Built-in Safety Net Traya’s commitment to personalisation plays a big role in managing safety. This hands-on approach allows for timely adjustments if side effects or discomfort arise. What Do Experts Say? Medical experts generally agree that personalised, doctor-led treatments carry fewer risks than over-the-counter, generic solutions. Traya’s plan aligns with these best practices, keeping safety a priority alongside effectiveness. Realistic View on Side Effects No treatment is entirely free of side effects. However, the goal is to keep them minimal and manageable. Common, mild side effects might include: These effects are usually short-lived and subside as the body adjusts to the treatment. Severe side effects are rare, especially under doctor supervision. Users are encouraged to report any discomfort promptly for plan adjustments. Why Some “Side Effects Reviews” Online Sound Alarming It’s natural to find negative experiences in online reviews, often because: Traya tries to minimise these risks by emphasising personalisation and regular follow-ups. When evaluating the safety of a treatment, especially one as layered as Traya’s, it’s crucial to go beyond surface-level reviews and understand the science. Traya’s combination of dermatology, Ayurveda, and nutrition is designed with care, using doctor-led personalisation to reduce risks. While mild side effects can occur, they are generally manageable and temporary. Regular monitoring and adjustments further enhance safety. If you’re considering Traya, knowing that the approach is scientifically grounded and medically supervised provides confidence in its overall safety profile. As always, open communication …

by Team SNFYI

Zingavita, a leading health and wellness startup specialized in providing high-quality, tailor-made nutraceuticals and supplements, today announced the successful closure of a ₹10 crore Pre-series A funding round led by Anicut Capital. The investment is poised to catalyse Zingavita’s expansion into new product development focusing on targeted nutrition. Following Dheeraj Nagpal’s recent appointment as cofounder at the company, the round welcomes marquee investors from the Pharma and FMCG space.  The Pre series A funding, which saw participation from influential investors such as Venkat Krishnan (CEO at BionPharma), Puru Gupta (founder, True Elements), Vishesh Chandiok (CEO, Grant Thornton Bharat), Nikhil Bhandarkar (founding partner, Panthera Peak) and other seasoned angel investors, will be pivotal for Zingavita’s growth and marketing initiatives. Additionally, the funds will fuel the brand’s entry into the Premium Ayurvedic Supplement space. The start-up will continue to focus on the products which are devoid of harmful additives like sugar, preservatives, artificial colours & flavours and thereby, bring transparency, innovation, and efficacy to the market. Ashvin Chadha, Co-Founder & CEO, Anicut Capital, commented on the investment, “We deeply believe in Zingavita’s ability to bring a revolution in the industry, given their differentiated offerings and strategic approach towards addressing the growing nutraceuticals market. Their strong commitment to quality and clean nutrition, along with a sharp focus on the Indian market’s unique needs, makes them an exceptional partner.” Sachin Goel, Co-Founder, Zingavita, expressing gratitude, said, “Zingavita is thrilled to welcome our new investors onboard. Anicut Capital continued backing and further investment have been a great encouragement. While we focus on creating formulations using superior quality ingredients intended to provide the best possible blend of ayurveda and modern nutritional science, this funding will enable us to accelerate our innovation cycle and meet our growth milestones in order to continue delivering on our promise of holistic nutrition for the entire family.” Commenting on the fundraise, Dheeraj Nagpal, Co-Founder, Zingavita said, “With Anicut Capital’s strong backing and our commitment to delivering high-quality, science-backed nutrition tailored for every family, we at Zingavita are committed to achieve our vision of becoming India’s leading health supplement brand. This funding will propel us to new heights, enabling us to innovate, expand, and continue offering cutting-edge products that cater to the evolving needs of our discerning customers.” He further added, “I am thrilled to be part of Zingavita’s growth story, especially at a time when the overall health supplement category is experiencing significant growth with a Compound Growth Rate (CGR) of 20-25%. The online market, valued at ₹20,000 crore, is witnessing a dynamic shift towards Nutraceutical and Ayurvedic segments. It’s noteworthy that Ayurvedic supplements are outpacing traditional modern nutrition, presenting a promising trend in the e-commerce space.” Zingavita’s portfolio consists of 25+ products available on leading e-commerce marketplaces like Amazon, Flipkart & Tata 1mg. Zingavita has led the launch of an disruptive array of health solutions aimed at enhancing overall well-being. Among these innovative offerings are India’s pioneering honey-sweetened gummies, meticulously crafted to cater to both children and adults. These gummies span various categories, including Eye Health for Kids, specifically formulated to counter screen time overload, Multivitamins …